As discussed earlier, EphA2 also amplifies the oncogenic signalling of the RTK erbB2 (HER2), and the loss of EphA2 in the mammary epithelium of mice slowed down tumour development and metastasis [46]. Here, ERBB2 is linked to neoplasm.